In light of our previous report that demonstrated the contribution of HERV-K to melanoma malignancy [26], we further investigated the activation of HERV-K in TVM-A12 melanoma cells during the expansion of CD133+ subpopulation in X-VIVO medium. This evidence concerns the gene PROM1 and melanoma.